TABLE IV.
Variable | Fine and Gray HR | Cause-specific HR | ||||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
Crude | p Value | Adjustedb | p Value | Crude | p Value | Adjusted | p Value | |
Recurrence | ||||||||
CPM | 0.51 | 0.001 | 0.61 | 0.02 | 0.51 | 0.001 | 0.62 | 0.03 |
No CPM | Reference | Reference | ||||||
| ||||||||
Death | ||||||||
CPM | 0.95 | 0.95 | 1.36 | 0.77 | 0.77 | 0.73 | 1.39 | 0.71 |
No CPM | Reference | Reference |
Censored: 299; recurrence: 299; death: 16.
Adjusted for patient, tumour and treatment characteristics (age, neoadjuvant chemotherapy, breast-conserving surgery followed by re-excision, multifocality, multicentricity, size of primary tumour, total number of involved lymph nodes, lymphovascular invasion, primary histologic type, pathologic subtype, estrogen and progesterone receptor status, adjuvant chemotherapy, and adjuvant radiation therapy).
CPM = contralateral prophylactic mastectomy.